Akiko Kowada (A Kowada)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

PLoS neglected tropical diseases

Epidemiology and infection

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Akiko Kowada
Cost-effectiveness of interferon- γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia. Epidemiology and infection 152 (2024)
Akiko Kowada
Cost-effectiveness of interferon- γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia. Epidemiology and infection 152 (2024)
Akiko Kowada
Cost-effectiveness of interferon- γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia. Epidemiology and infection 152 (2024)
Akiko Kowada
Cost-effectiveness of interferon- γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia. Epidemiology and infection 152 (2024)
Akiko Kowada
Cost-effectiveness of interferon-γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia. Epidemiology and infection (2024)
Akiko Kowada
Cost-Effectiveness of Population-Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation. Helicobacter 29 (4) (2024)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission. PLoS neglected tropical diseases 17 (2) (2023)
Akiko Kowada
Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study. BMC pulmonary medicine 22 (1) (2022)
Akiko Kowada, Masahiro Asaka
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis. Helicobacter 27 (3) (2022)
Akiko Kowada
A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening. Digestive diseases and sciences (2022)
Akiko Kowada
Greater public health impact of COVID-19 antigen detection tests. BMC medicine 19 (1) (2021)
Akiko Kowada, Masahiro Asaka
Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis. Helicobacter 26 (5) (2021)
Akiko Kowada
Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication. Digestive diseases and sciences 66 (12) (2021)
Akiko Kowada
Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. Scandinavian journal of gastroenterology 54 (6) (2019)
Akiko Kowada
Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan. Epidemiology and infection 146 (14) (2018)